Sophia Genetics (SOPH) and A.D.A.M. Innovations said Thursday they are partnering to bring liquid biopsy genomic testing to Japan.
The companies said they will also partner to commercialize a liquid biopsy companion diagnostic for personalized and precision cancer care in the country.
Shares of Sophia were up over 4% in recent trading.
Price: 4.47, Change: +0.18, Percent Change: +4.17
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.